Watson Pharmaceutical
This article was originally published in The Tan Sheet
Executive Summary
ANDA for loperamide HCI oral solution (1 mg/5 ml) approved on May 28. Watson expects to begin shipping loperamide OTC private label products in the third quarter of 1993. Other generic manufacturers with FDA clearance for 1 mg/5 ml loperamide liquid include Perrigo, Barre and Roxane